Lead Sheet

Real-time Expert BD Intelligence

CROs, CMOs and CDMOs worldwide depend on the PharmSource Lead Sheet for fresh leads, up-to-date contact information and reliable market intelligence. Quickly scout well-targeted new business opportunities. Learn more

Strategic Advantage

Proprietary Global Sourcing Intelligence in an Instant

Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more


In-Licensed Drug Products Can Be a Signal of Future Outsourcing

Of the more than 230 New Molecular Entities (NMEs) approved between 2003-2013, over one-third were in-licensed by the sponsor receiving the approval. Recent research by our team showed an unexpected and significant difference in…

Our Thinking

Outlook for the CMO Industry

The outlook for the contract manufacturing industry is being shaped by several significant trends. The well-financed pipeline makes the near term outlook favorable, but much depends on the number of new approvals for small and mid-size companies. Injectables CMOs should…

Market Intelligence

Demand and Supply for Contract Manufacturing of Conventional Injectable Drugs Through 2019

This extensive study estimates the demand for contract injectable manufacturing through 2019 and analyzes the supply and demand relationships for these services. Accompanied by a report on the cytotoxic injectable drug outlook, this expert report covers…

Trend Reports

CDMO and CRO Outlook: Robust Market Conditions Augur Growth, More M&A Activity Ahead

This PharmSource Trend Report analyzes the factors that drive bio/pharmaceutical development spending and the demand for contract development services.

Emerging bio/pharmaceutical companies are benefitting from a surge in financing from…